These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 400390

  • 1. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G, Armanini D, Fallo F, Mantero F.
    Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
    [No Abstract] [Full Text] [Related]

  • 2. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F, Ferraù O, Pitrone F, Luzza G, Russo A, Virga T.
    Boll Soc Ital Biol Sper; 1975 Dec 30; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C, Mantellini R, Fanti P, Sciarra F.
    Minerva Med; 1983 Apr 07; 74(14-15):791-7. PubMed ID: 6339999
    [Abstract] [Full Text] [Related]

  • 4. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV, Borghi C, Mussi A, Ambrosioni E.
    Minerva Cardioangiol; 1988 Oct 07; 36(10):503-7. PubMed ID: 3226562
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D, Achilli L.
    Minerva Cardioangiol; 1984 Sep 07; 32(9):581-7. PubMed ID: 6514202
    [No Abstract] [Full Text] [Related]

  • 6. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E, Cusi D, Colombo R, Pellizzoni M, Cesana B, Barlassina C, Soldati L, Bianchi G.
    J Hypertens Suppl; 1990 Sep 07; 8(4):S53-8. PubMed ID: 2175354
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical study of potassium canrenoate on raised intracranial pressure.
    Node Y, Nakazawa S.
    Adv Neurol; 1990 Sep 07; 52():557. PubMed ID: 2396562
    [No Abstract] [Full Text] [Related]

  • 9. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982 Sep 07; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Changes in nitrogen balance during the period following abdominal surgery and use of an injectable anti-aldosterone].
    Metivier Y, Guinot P, Saizy R, Meillaud J, Lioret N.
    Agressologie; 1976 Sep 07; 17(5):313-8. PubMed ID: 1015551
    [No Abstract] [Full Text] [Related]

  • 12. [Therapeutic effect of canrenoate potassium (soldactone) in patients after open-heart surgery].
    Matsuda K, Tatsuta N, Konishi Y, Minami K, Nishiwaki N, Yamasato A, Chiba Y, Ishihara H, Murata S, Shiraishi Y, Muraguchi T, Hikasa Y.
    Nihon Geka Hokan; 1982 May 01; 51(3):519-27. PubMed ID: 7138201
    [No Abstract] [Full Text] [Related]

  • 13. [Brain edema in neurosurgery. Trial with an aldosterone-antagonist (soldactone) (author's transl)].
    Anderes JP, de Tribolet N, Zander E.
    Schweiz Rundsch Med Prax; 1977 Aug 09; 66(32):1020-6. PubMed ID: 556440
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G, Cristodorescu R, Deutsch G, Berger E.
    Agressologie; 1977 Aug 09; 18(3):167-71. PubMed ID: 920909
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of the plasma renin activity and urinary aldosterone excretion in patients with essential hypertension treated with spironolactone. Note II].
    Bompiani GD, Scaduto P, Galluzzo A, Donatelli M, Morici ML, Mangano MT, Messina L.
    Minerva Cardioangiol; 1976 May 09; 24(5):352-9. PubMed ID: 1012481
    [No Abstract] [Full Text] [Related]

  • 17. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F, Milandri GL, Piemontese A, Macchia S, Simoni S, Dal Monte PR.
    Minerva Dietol Gastroenterol; 1984 May 09; 30(3):273-80. PubMed ID: 6504377
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S, Bellati G, Ideo G.
    Minerva Dietol Gastroenterol; 1984 May 09; 30(3):255-61. PubMed ID: 6504374
    [No Abstract] [Full Text] [Related]

  • 19. [Use of potassium canrenoate in cardiosurgery].
    Tufano R, Scopa M, Brando G, Leone D.
    Minerva Anestesiol; 1981 Apr 09; 47(4):149-54. PubMed ID: 7242963
    [Abstract] [Full Text] [Related]

  • 20. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone.
    Karlberg BE, Nilsson O, Tolagen K.
    Curr Ther Res Clin Exp; 1977 Jan 09; 21(1):10-20. PubMed ID: 401703
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.